PMID- 28674350 OWN - NLM STAT- MEDLINE DCOM- 20180105 LR - 20190115 IS - 1349-7235 (Electronic) IS - 0918-2918 (Print) IS - 0918-2918 (Linking) VI - 56 IP - 13 DP - 2017 TI - Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis. PG - 1637-1644 LID - 10.2169/internalmedicine.56.7019 [doi] AB - Objective Depression is reported to be relatively common in idiopathic pulmonary fibrosis (IPF) patients. Thus far, however, whether or not depression independently determines the health-related quality of life (HRQOL) has not been evaluated exclusively in IPF patients. We designed this study to identify independent determinants of the St. George' s Respiratory Questionnaire (SGRQ) score among various factors, including a depression scale, in IPF patients. Methods We retrospectively analyzed consecutive subjects with IPF who completed a systematic evaluation including pulmonary function tests, PaO(2) at rest, 6-minute walk test (6MWT), SGRQ, Baseline Dyspnea Index (BDI), and Hospital Anxiety and Depression Scale (HADS). All eligible patients in the present study had newly diagnosed IPF and had not received any prior treatments, such as antidepressants, pirfenidone, corticosteroids, immunosuppressants, or long-term oxygen therapy. Results The 121 patients with IPF included 99 men. On the SGRQ, mild to moderate disturbance was observed in the total and each component score. According to the HADS, 27 patients (22.3%) had borderline or definite depression. In a univariate regression analysis, the forced vital capacity (FVC), diffusion capacity of carbon monoxide (DLco), PaO(2) at rest, BDI, HADS for Anxiety (HADS-A) and Depression (HADS-D), 6-minute walk distance (6MWD), and lowest SpO(2) during the 6MWT were significantly correlated with the SGRQ total score. In a stepwise multiple regression model, BDI, 6MWD, and HADS-D were selected as independent determinants of the total SGRQ score. The total variance in this model was 59% (p<0.001). Conclusion We concluded that depression was a significant determinant of the HRQOL or health status in patients with IPF. FAU - Matsuda, Toshiaki AU - Matsuda T AD - Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan. AD - Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan. FAU - Taniguchi, Hiroyuki AU - Taniguchi H AD - Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan. FAU - Ando, Masahiko AU - Ando M AD - Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Japan. FAU - Kondoh, Yasuhiro AU - Kondoh Y AD - Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan. FAU - Kimura, Tomoki AU - Kimura T AD - Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan. FAU - Kataoka, Kensuke AU - Kataoka K AD - Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan. FAU - Nishimura, Koichi AU - Nishimura K AD - Department of Pulmonary Medicine, National Center for Geriatrics and Gerontology, Japan. FAU - Nishiyama, Osamu AU - Nishiyama O AD - Department of Respiratory Medicine and Allergology, Kindai University, Faculty of Medicine, Japan. FAU - Sakamoto, Koji AU - Sakamoto K AD - Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan. FAU - Hasegawa, Yoshinori AU - Hasegawa Y AD - Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan. LA - eng PT - Journal Article DEP - 20170701 PL - Japan TA - Intern Med JT - Internal medicine (Tokyo, Japan) JID - 9204241 SB - IM MH - Aged MH - Depression/*epidemiology MH - Female MH - Health Status MH - Humans MH - Idiopathic Pulmonary Fibrosis/*epidemiology/*physiopathology MH - Male MH - Middle Aged MH - Psychiatric Status Rating Scales MH - Quality of Life MH - Respiratory Function Tests MH - Retrospective Studies MH - *Severity of Illness Index PMC - PMC5519463 OTO - NOTNLM OT - 6-minute walk test OT - depression OT - dyspnea OT - health status OT - idiopathic pulmonary fibrosis EDAT- 2017/07/05 06:00 MHDA- 2018/01/06 06:00 PMCR- 2017/07/01 CRDT- 2017/07/05 06:00 PHST- 2017/07/05 06:00 [entrez] PHST- 2017/07/05 06:00 [pubmed] PHST- 2018/01/06 06:00 [medline] PHST- 2017/07/01 00:00 [pmc-release] AID - 10.2169/internalmedicine.56.7019 [doi] PST - ppublish SO - Intern Med. 2017;56(13):1637-1644. doi: 10.2169/internalmedicine.56.7019. Epub 2017 Jul 1.